SG/CALL/EDWARDS LIFESCIENCES/110/0.1/20.06.25 | Market Closed - Boerse Frankfurt Warrants 20:37:46 20/05/2024 BST | ||
| 1.15 EUR | -2.54% |
|
| Current month | +8.49% | ||
| 1 month | -4.96% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 20/05/24 | 1.15 | -2.54% |
| 17/05/24 | 1.18 | -5.60% |
| 16/05/24 | 1.25 | +2.46% |
| 15/05/24 | 1.22 | +15.09% |
| 14/05/24 | 1.06 | +10.42% |
Real-time Boerse Frankfurt Warrants
Last update May 20, 2024 at 08:37 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SW7LNW |
| ISIN | DE000SW7LNW0 |
| Date issued | 12/03/2024 |
| Strike | 110 $ |
| Maturity | 20/06/2025 (396 Days) |
| Parity | 10 : 1 |
| Emission price | 1.59 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.67 € |
|---|---|
| Lowest since issue | 0.91 € |
| Spread | 0.01 € |
| Spread % | 0.85% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
89.78
USD
Average target price
95.9
USD
Spread / Average Target
+6.82%
- Stock Market
- Warrants
- Warrant
